The legislation proposed the formation of a Medicare Drug Shortage Mitigation Program tasked with improving contracting and purchasing in the pharmaceutical supply chain by 2027, according to The Hill.
Other provisions would require Medicare suppliers to create stricter standards to bolster the reliability and transparency of generic drug purchasing in order to receive Medicare payment incentives, the publication said.
Another provision would require contracts for a minimum of three years with manufacturers, purchase volume commitments and transparency about manufacturer quality issues, The Hill reported.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
